Business Model

Business Model

IRICoR has a very flexible business model adapted to the needs of the private sector that aims at de-risking the discovery and commercialization of proprietary paradigm-shifting therapeutic approaches in oncology, immunology and related indications. IRICoR’s model is based on four (4) main pillars.

Click the icons to view the contents

Investment in innovative commercialization-focused projects

In-house cutting-edge technologies, platforms and affiliated clinical facilities

Financial and professional support to selected projects

Identification and Establishment of targeted partnerships towards most valuable commercialization